About Prellis Biologics
Prellis Biologics is a company based in San Francisco (United States) founded in 2016.. Prellis Biologics has raised $69.85 million across 7 funding rounds from investors including Khosla Ventures, Celesta and Avidity Partners. The company has 22 employees as of December 31, 2020. Prellis Biologics offers products and services including EXIS™ Platform and LNO™. Prellis Biologics operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter San Francisco, United States
- Employees 22 as on 31 Dec, 2020
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Prellis Biologics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$69.85 M (USD)
in 7 rounds
-
Latest Funding Round
$35 M (USD), Series C
Jul 06, 2022
-
Investors
Khosla Ventures
& 9 more
-
Employee Count
22
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prellis Biologics
Prellis Biologics offers a comprehensive portfolio of products and services, including EXIS™ Platform and LNO™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-integrated system for rapid antibody screening and therapeutic development.
3D bioprinted organoids replicating human immune responses for research.
Unlock access to complete
Funding Insights of Prellis Biologics
Prellis Biologics has successfully raised a total of $69.85M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $35.0M
-
First Round
First Round
(31 May 2017)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series C - Prellis Biologics | Valuation | Celesta Capital , Avidity Partners | |
| Jul, 2021 | Amount | Series B - Prellis Biologics | Valuation | Celesta Capital | |
| May, 2020 | Amount | Series A - Prellis Biologics | Valuation | Future Ventures , Khosla Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prellis Biologics
Prellis Biologics has secured backing from 10 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Celesta and Avidity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prellis Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prellis Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prellis Biologics Comparisons
Competitors of Prellis Biologics
Prellis Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Prellis Biologics
Frequently Asked Questions about Prellis Biologics
When was Prellis Biologics founded?
Prellis Biologics was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Prellis Biologics located?
Prellis Biologics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Prellis Biologics a funded company?
Prellis Biologics is a funded company, having raised a total of $69.85M across 7 funding rounds to date. The company's 1st funding round was a Series A of $4.3M, raised on May 31, 2017.
How many employees does Prellis Biologics have?
As of Dec 31, 2020, the latest employee count at Prellis Biologics is 22.
What does Prellis Biologics do?
Prellis Biologics was founded in 2016 in San Francisco, United States, within the biotechnology sector. Human tissues are constructed using 3D bioprinting technology for drug development purposes, while human organs for transplantation are also being developed. A laser-based printing process is employed to form layers of extracellular matrix with embedded cells, eliminating needs for cell-seeding or curing. Organoids have been created, and prototype microvasculature is under construction.
Who are the top competitors of Prellis Biologics?
Prellis Biologics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Prellis Biologics offer?
Prellis Biologics offers EXIS™ Platform and LNO™.
Who are Prellis Biologics's investors?
Prellis Biologics has 10 investors. Key investors include Khosla Ventures, Celesta, Avidity Partners, SOSV, and True Ventures.